How will INVEST and other hypertension trials change clinical practice?

Clinical Cardiology

Volumn 24, Issue 11 SUPPL., 2001, Pages

  Conti, R C ^a   Cooper DeHoff, R M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical trials; Hypertension; INVEST; Practice guidelines; Risk stratification; Treatment strategies

Indexed keywords

TRANDOLAPRIL; VERAPAMIL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RESPONSIBILITY; TREATMENT PLANNING;

EID: 0034759211     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960241708     Document Type: Conference Paper

References (13)

1. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): An Internet-based randomized trial in coronary artery disease patients with hypertension
2. Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
3. Baseline characteristics and early blood pressure control in the CONVINCE Trial
4. Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
5. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
6. Prevention of coronary heart disease in clinical practice
7. Self-reported hypertension treatment practices among primary care physicians: Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine
8. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: Principal results from EUROASPIRE II Euro Heart Survey Programme
9. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review
10. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
11. A prospective intervention trial of calcium antagonist therapy in hypertension
12. Update on the systolic hypertension in Europe (Syst-Eur) trial
13. Characteristics and blood pressure responses of 6,057 Hispanic hypertensive patients with coronary artery disease enrolled in the INVEST